The Form 4 filing, a report of insider stock trades, was filed on November 12, 2026. It covers sales made on November 10, 2026, by Peter Anevski, Progyny's chief executive officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 51,496 |
| Price | $35.84 |
| Total Transaction Value | $1,845,853.85 |
| Insider | |
| Ticker Symbol | PGNY |
| Company | Progyny, Inc. |
| Insider Name | Anevski Peter |
| Insider Title | CHIEF EXECUTIVE OFFICER |
| Sector - Industry | Healthcare - Healthcare Plans |
| Holdings | |
| Total Shares Owned After Transaction | 710,972 |
| Position Size Change | 6.75% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Progyny (PGNY) shares. The transactions carry code S, which identifies a sale. The filing covers two sales by one insider.
What was the average price of the transaction?
The average sale price was $35.84 per share, rounded to the nearest cent. Separate prices for each of the two sales were not included in the available transaction details.
How did this transaction affect the insider's holdings?
Peter Anevski sold 51,496 shares and reported owning 710,972 shares afterward. The shares sold made up 6.75% of the shares he held before the sales.
What's the total transaction value?
The two sales had a total value of $1,845,853.85, rounded to the nearest cent. This amount covers all 51,496 shares sold across both transactions.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for these sales. The filing's footnote text was not provided, so any further terms or circumstances remain unknown.
For research purposes only; not investment advice.